Tender

The Supply, Delivery, Installation and Maintenance of Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2)

MEDICINES DISCOVERY CATAPULT

This public procurement record has 1 release in its history.

Tender

14 Oct 2021 at 09:09

Summary of the contracting process

The Medicines Discovery Catapult (MDC) is currently seeking tenders for the supply, delivery, installation, and maintenance of three Multimode Plate Readers and two Absorbance Plate/Cuvette Readers, with a total value of £195,000. This procurement falls under the category of laboratory, optical, and precision equipment, specifically aimed at enhancing the MDC’s capabilities for collaborative research and development in innovative diagnostics and therapeutics. The tender process is in the active phase and is being conducted through an open procurement method. The submission deadline is set for 15 November 2021, with the award period commencing shortly thereafter.

This tender presents substantial opportunities for companies specialising in laboratory equipment and related technologies to engage with a leading organisation in the healthcare sector. Businesses that manufacture precision scientific instruments, diagnostic technologies, and services related to the installation and maintenance of such equipment would be particularly well-suited to compete for this contract. By participating, these companies can contribute to the advancement of critical health initiatives while potentially expanding their market reach within a collaborative and high-value industry.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

The Supply, Delivery, Installation and Maintenance of Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2)

Notice Description

Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC wishes to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. This tender is for Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2), which will be used in the new facility.

Lot Information

Lot 1

Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC wishes to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. This tender is for Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2), which will be used in the new facility.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02eba9
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/025660-2021
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

38 - Laboratory, optical and precision equipments (excl. glasses)


CPV Codes

38000000 - Laboratory, optical and precision equipments (excl. glasses)

Notice Value(s)

Tender Value
£195,000 £100K-£500K
Lots Value
£195,000 £100K-£500K
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
14 Oct 20214 years ago
Submission Deadline
15 Nov 2021Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
MEDICINES DISCOVERY CATAPULT
Contact Name
Mr Kieran McGowan
Contact Email
kieran.mcgowan@md.catapult.org.uk
Contact Phone
+44 1625708394

Buyer Location

Locality
CHESHIRE
Postcode
SK10 4ZF
Post Town
Stockport
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD6 Cheshire
Small Region (ITL 3)
TLD62 Cheshire East
Delivery Location
TLD62 Cheshire East

Local Authority
Cheshire East
Electoral Ward
Chelford
Westminster Constituency
Tatton

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02eba9-2021-10-14T10:09:55+01:00",
    "date": "2021-10-14T10:09:55+01:00",
    "ocid": "ocds-h6vhtk-02eba9",
    "initiationType": "tender",
    "tender": {
        "id": "DN575874",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "The Supply, Delivery, Installation and Maintenance of Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2)",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "38000000",
            "description": "Laboratory, optical and precision equipments (excl. glasses)"
        },
        "mainProcurementCategory": "goods",
        "description": "Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC wishes to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. This tender is for Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2), which will be used in the new facility.",
        "value": {
            "amount": 195000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC wishes to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. This tender is for Multimode Plate Readers (x3) and Absorbance Plate/Cuvette Readers (x2), which will be used in the new facility.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Quality - all criteria are stated in the procurement documents.",
                            "type": "quality",
                            "description": "70"
                        },
                        {
                            "name": "Price - all criteria are stated in the procurement documents.",
                            "type": "quality",
                            "description": "30"
                        },
                        {
                            "type": "price",
                            "description": "30"
                        }
                    ]
                },
                "value": {
                    "amount": 195000,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "endDate": "2022-10-31T23:59:59Z"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": false,
                "status": "active"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKD62"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=38309d8b-362c-ec11-810e-005056b64545&projectId=e3229498-2e2c-ec11-810e-005056b64545",
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "coveredBy": [
            "GPA"
        ],
        "tenderPeriod": {
            "endDate": "2021-11-15T12:00:00Z"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "awardPeriod": {
            "startDate": "2021-11-15T12:05:00Z"
        },
        "bidOpening": {
            "date": "2021-11-15T12:05:00Z"
        },
        "hasRecurrence": false
    },
    "parties": [
        {
            "id": "GB-FTS-23690",
            "name": "Medicines Discovery Catapult",
            "identifier": {
                "legalName": "Medicines Discovery Catapult"
            },
            "address": {
                "streetAddress": "Block 35, Mereside, Alderley Park",
                "locality": "Cheshire",
                "region": "UKD62",
                "postalCode": "SK10 4ZF",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Mr Kieran McGowan",
                "telephone": "+44 1625708394",
                "email": "Kieran.McGowan@md.catapult.org.uk",
                "url": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=38309d8b-362c-ec11-810e-005056b64545&projectId=e3229498-2e2c-ec11-810e-005056b64545"
            },
            "roles": [
                "buyer",
                "reviewBody"
            ],
            "details": {
                "url": "https://md.catapult.org.uk/",
                "buyerProfile": "https://md.catapult.org.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "description": "Drug Discovery / Health"
                    },
                    {
                        "scheme": "COFOG",
                        "description": "Drug Discovery / Health"
                    }
                ]
            },
            "additionalContactPoints": [
                {
                    "email": "Kieran.McGowan@md.catapult.org.uk"
                }
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-23690",
        "name": "Medicines Discovery Catapult"
    },
    "language": "en"
}